Pfizer HighCon Powder Handling Case Study

The project expanded high-containment oral-solid-dose production

Pfizer opened the HighCon facility at its Freiburg site in May 2022 after a reported investment of almost €300 million.

The company described an automated process from powder to tablet and stated that the new facility could add up to seven billion tablets and capsules per year.

These are site-level statements. They do not define the capacity of an individual powder-handling machine.

The powder boundary starts at raw-material discharge

Published project material identifies big-bag, sack and drum discharge as part of the high-containment raw-material feed station.

Each container interface has to control exposure during connection, discharge, liner handling, residual-product recovery, disconnection and waste removal.

Containment is a task: A closed valve or liner does not prove operator protection by itself. The complete task and credible failures have to be assessed against a health-based exposure target.

Facility and process controls work together

Pfizer and Siemens describe connected production and building systems, including automation and environmental control.

Room pressure, ventilation and alarms support the equipment boundary, but they should not be used to excuse leakage at a transfer interface.

NIOSH’s hierarchy of controls places enclosure and other engineering controls ahead of routine dependence on personal protective equipment.

Product protection is the other containment direction

High containment must prevent active material from reaching people and adjacent areas while also preventing foreign material, cleaning residues and previous products from entering the batch.

FDA guidance requires controls and validated cleaning where potent materials could create cross-contamination risk in shared equipment or facilities.

The cleaning strategy should define dismantling, closed cleaning where used, inaccessible product-contact surfaces, sampling method, analytical sensitivity and acceptance limits.

Automation needs defined abnormal states

A highly automated line still needs an engineered response to a broken liner, failed extraction, lost pressure cascade, blocked discharge, filter fault or interrupted transfer.

The response should place equipment in a stable state, contain exposed material and tell the operator what can be safely handled next.

Data records should preserve material identity, equipment state, alarms and disposition decisions for affected product.

Raw-material interfaces set the containment challenge

Big bags, sacks and drums arrive with different closure details, residual quantities and handling motions.

A contained discharge station has to manage the outer surface, the product-facing connection and the empty package after transfer.

The highest exposure can occur during a short intervention such as untying a liner, clearing a fold or removing a package that appears empty.

Task-based testing should therefore include these actions. A pressure reading from the enclosure during uninterrupted flow does not represent the complete operator exposure.

Transfer equipment must preserve the pressure boundary

Feeders, vacuum receivers and valves create moving interfaces through the containment envelope.

Seal wear, filter loading and a blocked discharge can change local pressure and release behaviour.

Maintenance criteria should identify the point at which a seal, glove or filter no longer supports the qualified state, rather than waiting for visible powder outside the machine.

What the published evidence does and does not establish

Pfizer’s sources establish the facility opening, investment, broad process scope and stated production capacity.

They do not publish task-level occupational exposure measurements, cleaning-validation limits, individual machine capacity or intervention frequency.

Those values must remain project records rather than being guessed from the facility description.

Scale does not remove the need for local proof

The stated additional annual capacity describes the plant’s production potential at opening. It is not evidence for transfer rate, containment performance or availability at a particular unit operation.

A comparable project should allocate acceptance criteria to each boundary: discharge, conveyance, dosing, processing, cleaning and packaging.

That separation makes troubleshooting much less theatrical. When a line misses output, engineers can distinguish a starved feeder from a containment interlock or a slow cleaning cycle instead of blaming “automation” as one large box.

Acceptance evidence for a comparable facility

• Health-based exposure limits and a task map for normal work, cleaning, maintenance and failures.
• Surrogate or product-specific containment testing under realistic operator actions.
• Cleaning validation for accessible and difficult product-contact surfaces.
• Alarm, pressure-cascade and ventilation challenge tests.
• Material genealogy and product-disposition logic after interruptions.
• Documented recovery from a containment breach without spreading contamination.

See high-containment powder handling for the underlying design framework.